Renovos Biologics Limited

📍 Southampton, United Kingdom🗓 Founded 2017👥 9 employees💰 Last funded Aug 2023
Biotechnology Research🌐 renovos.co.uk
Website LinkedIn
Renovos is a new regenerative medicine company capitalising on the decades of world-class stem cell and orthopaedic research from the University of Southampton. Renovos is developing next-generation regenerative medicine solutions, based on a synthetic nanoclay gel technology platform, Renovite. Renovos offers a complementary range of products and services to address the needs of researchers and clinicians, developing solutions for tissue healing that is quicker, safer and more cost-effective.
2
Total investors
1
Early stage
0
Mid stage
1
Late stage
2017
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
United Kingdom
1
Spain
1
Frequently asked questions
Who invested in Renovos Biologics Limited?
Renovos Biologics Limited has 2 investors on record on gritt.io, including 1 early-stage backers and 1 late-stage investors.
When did Renovos Biologics Limited last raise funding?
The most recent investment in Renovos Biologics Limited recorded on gritt.io was in August 2023.
When was Renovos Biologics Limited founded?
Renovos Biologics Limited was founded in 2017.
What industry is Renovos Biologics Limited in?
Renovos Biologics Limited operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Renovos Biologics Limited based?
Renovos Biologics Limited is headquartered in Southampton, United Kingdom.